FITC-Linked Monoclonal Antibody to Cross Linked C-Telopeptide Of Type I Collagen (CTXI)
- Product No.LAA665Hu84
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceAntibody labeling
- Ig Isotype IgG
- PurificationProtein A + Protein G affinity chromatography
- Original Antibody MAA665Hu21-Monoclonal Antibody to Cross Linked C-Telopeptide Of Type I Collagen (CTXI)
- Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
- Organism Species Moren/a
- ApplicationsWB; IHC; ICC; IF.
If the antibody is used in flow cytometry, please check FCM antibodies.
- DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
For more details, please contact local distributors! US$ 442
For more details, please contact local distributors! US$ 632
For more details, please contact local distributors! US$ 1580
For more details, please contact local distributors! US$ 6320
For more details, please contact local distributors!
The antibody is a mouse monoclonal antibody raised against CTXI. It has been selected for its ability to recognize CTXI in immunohistochemical staining and western blotting.
Optimal working dilutions must be determined by end user.
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
|journal of bone and mineral research||Atp6v0d2 Is an Essential Component of the Osteoclast-Specific Proton Pump That Mediates Extracellular Acidification in Bone Resorption PubMed: PMC2672205|
|Bone||Borage and fish oils lifelong supplementation decreases inflammation and improves bone health in a murine model of senile osteoporosis PubMed: 21664309|
|Trials||Is there benefit in optimising heart failure treatment in over-80 year-old patients? (HF-80 study): study protocol for a randomized controlled trial. Trials: 1745-6215|
|Journal of Biological Chemistry||TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation PubMed: 22773835|
|The Journal of Clinical Endocrinology & Metabolism||A Mediterranean Diet Enriched with Olive Oil Is Associated with Higher Serum Total Osteocalcin Levels in Elderly Men at High Cardiovascular Risk PubMed: PMC3462931|
|Endocrinology||Oxytocin Reverses Ovariectomy-Induced Osteopenia and Body Fat Gain Endocrine: Source|
|Am J Physiol Endocrinol Metab.||DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats Pubmed:25053403|
|The American Journal of Cardiology||Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease Pubmed:25073565|
|Rheumatology (Oxford).||Bone resorption correlates with the frequency of CD5+ B cells in the blood of patients with rheumatoid arthritis Pubmed:25193807|
|XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa) Pubmed:25284315|
|Rheumatology International||The presence of FCGR2B promoter or transmembrane region variant alleles leads to reduced serum IL-6 levels in rheumatoid arthritis Pubmed:25630523|
|The Journal of Biological Chemistry||5-azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival Pubmed:25691576|
|Scandinavian Journal of Clinical and Laboratory Investigation||Osteocartilaginous metabolic markers change over a 3-week stage race in pro-cyclists PubMed: 26174975|
|AIDS||Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patients PubMed: 26372384|
|the journal of rheumatology||Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis PubMed: 26472417|
|Int J Mol Med||Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway PubMed: 26677102|
|the journal of biological chemistry||Mutation in Osteoactivin Promotes RANKL-Mediated Osteoclast Differentiation and Survival, but Inhibits Osteoclast Function PubMed: 25837253|
|frontiers in endocrinology||Oxytocin reverses osteoporosis in a sex-dependent manner PubMed: 26042090|
|PLoS One.||The RIP1–RIP3 Complex Mediates Osteocyte Necroptosis after Ovariectomy in Rats pmc:PMC4795547|
|J Cell Physiol||Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the DownreCavia (Guinea pig )lation of Rankl-Induced Nf-κb and Nfatc1 Activities Pubmed:26060084|
|FASEB Journal||N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities. pubmed:27530978|
|Metabolism.||High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients. pubmed:28521869|
|journal of science and medicine in sport||The effect of calcium and vitamin D supplementation on bone health of male Jockeys. pubmed:27568072|
|Chemico-Biological Interactions||Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway pubmed:27387537|
|Epilepsy Research||The effect of lamotrigine and phenytoin on bone turnover and bone strength: A prospective study in Wistar rats pubmed:27838501|
|Bone||Reduced femoral bone mass in both diet-induced and genetic hyperlipidemia mice pubmed:27669658|
|Journal of Vascular Surgery||A potential role for glycated cross-links in abdominal aortic aneurysm disease. pubmed:27624703|
|Institute of Pharmacology||Effects of long-term administration of pantoprazole on bone mineral density in young male rats. pubmed:27552060|
|Biomedicine & Pharmacotherapy||Anti-osteoporotic effects of an antidepressant tianeptine on ovariectomized rats S0753332216322752|
|European Journal of Pharmacology||Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury pubmed:28479140|
|APPLIED SPECTROSCOPY||Side-Effects of Convulsive Seizures and Anti-Seizure Therapy on Bone in a Rat Model of Epilepsy pubmed:28905646|
|Clinical Nutrition||Obesity status influences the relationship among serum osteocalcin, iron stores and insulin sensitivity pubmed:29050649|
|Oncotarget||A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice. pubmed:28060768|
|中国骨质疏松杂志||骨形成指标PINP 与骨吸收指标β-CTX 在2 型糖尿病合并骨质疏松中作用的研究. 10.3969/j.issn.1006-7108.2017.03.009|
|BioMed Research International||Optimization of the Time Window of Interest in Ovariectomized Imprinting Control Region Mice for Antiosteoporosis Research pubmed:29119115|
|Cell Death And Differentiation||TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42 Pubmed:29358671|
|Journal of Periodontology||The role of androgens on periodontal repair in female rats Pubmed:29683499|
|Life Sciences||Myricetin ameliorates glucocorticoid-induced osteoporosis through the ERK signaling pathway Pubmed:29883721|
|European Journal of Pharmacology||The effect of levetiracetam on rat bone mineral density, bone structure and biochemical markers of bone metabolism Pubmed:29428468|
|Journal of Clinical Densitometry||Geometric and mechanical bone response to a multidisciplinary weight loss intervention in adolescents with obesity: The ADIBOX study Pubmed:30076009|
|Pharmacology||Effects of Amlodipine on Bone Metabolism in Orchidectomised Spontaneously Hypertensive Rats Pubmed:29898457|
|Experimental and Therapeutic Medicine||Liraglutide exerts a bone‑protective effect in ovariectomized rats with streptozotocin‑induced diabetes by inhibiting osteoclastogenesis Pubmed:29805533|
|Experimental and Therapeutic Medicine||Combination therapy with BMP‑2 and psoralen enhances fracture healing in ovariectomized mice 10.3892:etm.2018.6353|
|Tumor Biology||Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling Pubmed:29687745|